Sign in
Taking people in United StatesNo phase

Collecting tissue and blood samples from adults with melanoma for research

Collects tissue and blood samples from adults with melanoma to study disease growth.

Key facts

Who runs it
Vanderbilt-Ingram Cancer Center
Where
Nashville, United StatesSee the site
Trial code
Registry title
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
Status
Recruiting
People taking part
3,000 people, planned
Started
3 Jun 2010
Expected to end
Jun 2027
Type of study
Observational
Treatments tested
  • Tissue and blood collection
Record updated
19 September 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a melanoma diagnosis confirmed under the microscope. Tissue and blood are collected and stored for research.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Melanoma confirmed by pathology (examination of tissue).
Earlier treatment
Not required. People who already had a diagnostic or treatment procedure can join if they have not yet been asked to take part.

Main reasons for not taking part

  • Significant reasons that make drawing blood unsafe, such as severe anemia (these people can still join if they give a tissue block or 10-15 unstained slides)
  • Unable or unwilling to give consent

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Pathologically-proven diagnosis of melanoma
  • Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible

Who cannot take part

  • Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol
  • Any patient unable or unwilling to provide consent

Where in United States

  • Vanderbitl-Ingram Cancer CenterNashville, United StatesContact: Vanderbilt-Ingram Service for Timely AccessTaking people

About the trial

What the trial wants to find out

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Treatments tested

  • Tissue and blood collection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Plain-language title
Collecting tissue and blood samples from adults with melanoma for researchGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
19 September 2025